Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2018-1840
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM WebSphere Application Server 8.5 and 9.0 could allow a remote attacker to gain elevated privileges on the system, caused when a security domain is configured to use a federated repository other than global federated repository and then migrated to a newer release of WebSphere Application Server. IBM X-Force ID: 150813.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM WebSphere Application Server 权限许可和访问控制漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM WebSphere Application Server(WAS)是美国IBM公司开发并发行的一款应用服务器产品,它是Java EE和Web服务应用程序的平台,也是IBM WebSphere软件平台的基础。 IBM WAS 9.0版本和8.5版本中存在提权漏洞。远程攻击者可利用该漏洞提升权限。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMWebSphere Application Server 8.5 -
II. Public POCs for CVE-2018-1840
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2018-1840
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2018-1840

No comments yet


Leave a comment